Yan Kaijing and Li Yunhui signed an agreement to acquire 11% stake in Tasly Pharmaceutical Group Co., Ltd. (SHSE:600535) from Yan Xijun and Wu Nai Feng for CNY 4 million on March 27, 2016. Under the terms of the deal, Yan Xijun plans to transfer 5% stake to Yan Kaijing for CNY 1.8 million and Wu Nai Feng plans to transfer 6% stake to Li Yunhui for CNY 2.16 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.53 CNY | -1.76% | -6.20% | -14.63% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.63% | 3B | |
+38.28% | 6.07B | |
-16.91% | 4.42B | |
+5.14% | 3.26B | |
-4.12% | 2.47B | |
+42.14% | 1.89B | |
-10.63% | 1.63B | |
-2.71% | 1.6B | |
-12.26% | 1.54B | |
+42.59% | 1.47B |
- Stock Market
- Equities
- 600535 Stock
- News Tasly Pharmaceutical Group Co., Ltd
- Yan Kaijing and Li Yunhui signed an agreement to acquire 11% stake in Tasly Pharmaceutical Group Co., Ltd. from Yan Xijun and Wu Nai Feng for CNY 4 million.